» Articles » PMID: 11447502

Changes in Sodium or Glucose Filtration Rate Modulate Expression of Glucose Transporters in Renal Proximal Tubular Cells of Rat

Overview
Journal J Membr Biol
Date 2001 Jul 12
PMID 11447502
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Renal glucose reabsorption is mediated by luminal sodium-glucose cotransporters (SGLTs) and basolateral facilitative glucose transporters (GLUTs). The modulators of these transporters are not known, and their substrates glucose and Na+ are potential candidates. In this study we examined the role of glucose and Na+ filtration rate on gene expression of glucose transporters in renal proximal tubule. SGLT1, SGLT2, GLUT1 and GLUT2 mRNAs were assessed by Northern blotting; and GLUT1 and GLUT2 proteins were assessed by Western blotting. Renal cortex and medulla samples from control rats (C), diabetic rats (D) with glycosuria, and insulin-resistant 15-month old rats (I) without glycosuria; and from normal (NS), low (LS), and high (HS) Na+-diet fed rats were studied. Compared to C and I rats, D rats increased (P < 0.05) gene expression of SGLT2 by approximately 36%, SGLT1 by approximately 20%, and GLUT2 by approximately 100%, and reduced (P < 0.05) gene expression of GLUT1 by more than 50%. Compared to NS rats, HS rats increased (P < 0.05) SGLT2, GLUT2, and GLUT1 expression by approximately 100%, with no change in SGLT1 mRNA expression, and LS rats increased (P < 0.05) GLUT1 gene expression by approximately 150%, with no changes in other transporters. In summary, the results showed that changes in glucose or Na+ filtrated rate modulate the glucose transporters gene expression in epithelial cells of the renal proximal tubule.

Citing Articles

Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications.

Leon-Jimenez D, Sridhar V, Lopez-Mendoza M, Scholtes R, Schmieder R, Cherney D Clin Kidney J. 2025; 18(1):sfae370.

PMID: 40008354 PMC: 11852268. DOI: 10.1093/ckj/sfae370.


The Abnormal Expression of Tubular SGLT2 and GULT2 in Diabetes Model Mice with Malocclusion-Induced Hyperglycemia.

Kajiwara K, Tamaoki S, Sawa Y Biomedicines. 2025; 13(2).

PMID: 40002681 PMC: 11853642. DOI: 10.3390/biomedicines13020267.


Exacerbation of diabetes due to F. Nucleatum LPS-induced SGLT2 overexpression in the renal proximal tubular epithelial cells.

Seki A, Kajiwara K, Teramachi J, Egusa M, Miyawaki T, Sawa Y BMC Nephrol. 2025; 26(1):38.

PMID: 39856606 PMC: 11760738. DOI: 10.1186/s12882-025-03965-z.


Clinical Recommendations for Managing Genitourinary Adverse Effects in Patients Treated with SGLT-2 Inhibitors: A Multidisciplinary Expert Consensus.

Gorgojo-Martinez J, Gorriz J, Cebrian-Cuenca A, Castro Conde A, Velasco Arribas M J Clin Med. 2024; 13(21).

PMID: 39518647 PMC: 11546491. DOI: 10.3390/jcm13216509.


Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states.

Kanbay M, Copur S, Guldan M, Ozbek L, Hatipoglu A, Covic A Clin Kidney J. 2024; 17(7):sfae195.

PMID: 39050867 PMC: 11267238. DOI: 10.1093/ckj/sfae195.